COVID-19 L·OVE REPOSITORY IS HIGHLY COMPREHENSIVE AND CAN BE USED AS A SINGLE SOURCE FOR COVID-19 STUDIES

Simple item page
dc.catalogadoraba
dc.contributor.authorVerdugo Paiva, Francisca
dc.contributor.authorVergara, C.
dc.contributor.authorÁvila, Camila
dc.contributor.authorCastro, J.
dc.contributor.authorCid, J.
dc.contributor.authorContreras, V.
dc.contributor.authorJara, I.
dc.contributor.authorJiménez, Valentina
dc.contributor.authorHa Lee, Min
dc.contributor.authorMuñoz, Magdalena
dc.contributor.authorRojas Gómez, Ana María
dc.contributor.authorRoson Rodríguez, P.
dc.contributor.authorSerrano Arevalo, K.
dc.contributor.authorSilva Ruz, Ivan
dc.contributor.authorVásquez Laval, J.
dc.contributor.authorZambrano Achig, Paula
dc.contributor.authorZavadzki, Giovanna
dc.contributor.authorRada G., Gabriel
dc.date.accessioned2025-04-01T16:01:28Z
dc.date.available2025-04-01T16:01:28Z
dc.date.issued2021
dc.description.abstractObjective: COVID-19 Living OVerview of Evidence (COVID-19 L·OVE) is a public repository and classification platform for COVID-19 articles. The repository contains over 430,000 articles as of 20 September 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews. Methods: Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L·OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L·OVE repository. We estimated the currency as the percentage of studies that were available in the COVID-19 L·OVE repository at the time the systematic reviews conducted their own search. Results: We identified 83 eligible systematic reviews that included 2132 studies. COVID-19 L·OVE had an overall comprehensiveness of 99.67% (2125/2132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L·OVE instead of searching the original sources, was 96.48% (2057/2132). Both the comprehensiveness and the currency were 100% for randomised trials (82/82). Conclusion: The COVID-19 L·OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processes.
dc.format.extent14 páginas
dc.fuente.origenORCID
dc.identifier.doi10.1101/2021.09.21.21263849
dc.identifier.urihttps://doi.org/10.1101/2021.09.21.21263849
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/103088
dc.information.autorucEscuela de Medicina; Rada G., Gabriel; 0000-0003-2435-0710; 11470
dc.language.isoen
dc.nota.accesocontenido completo
dc.revistamedRxiv. The preprint server for health sciences
dc.rightsacceso abierto
dc.rights.licenseAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleCOVID-19 L·OVE REPOSITORY IS HIGHLY COMPREHENSIVE AND CAN BE USED AS A SINGLE SOURCE FOR COVID-19 STUDIES
dc.typepreprint
sipa.codpersvinculados11470
sipa.trazabilidadORCID;2025-03-03
Files
Collections
Artículos de revistas